{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/156783120"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "SAN DIEGO, Dec. 3, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, today announced the initiation of a compassionate-use clinical program to treat individuals infected with Hepatitis C virus (HCV)." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "sys-con.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/424431659"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/156783120" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/318770589"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/156783120"] } } }
